Aisa Pharma

Aisa Pharma is committed to introducing novel disease-altering therapies for patients with uncommon severe conditions that are rarely the focus of large pharmaceutical development initiatives and have limited effective treatment choices. The FDA classifies rare illnesses as 'orphan' when they impact